South Korean authorities have organized influenza vaccinations for 30 million people to avoid an outbreak of the virus concurrently with COVID-19. After the death of dozens of vaccinated people, it was decided not to stop the vaccination campaign.
how reports The BBC, citing South Korean health authorities, was the first to die of a 17-year-old boy two days after being vaccinated. Reports of other victims soon began to arrive. All of them were elderly people of 70-80 years old, mainly with chronic diseases. At that time, 13 million citizens had already been vaccinated in the country.
The South Korean Medicine Association then called on the authorities to stop vaccinations pending information on the cause of death, so as not to undermine confidence in vaccination. but The Agency for Disease Control and Prevention has decided to continue the vaccination campaign.
“The number of deaths has increased, but the likelihood that death was due to vaccinations is very low,” said CEO Jung Eun Kyung.
Professor Kim Joon-kon, who has led the investigation into these cases, urged South Koreans not to give up vaccinations. According to him, so far, experts have not received any evidence that the cause of death was the vaccine. Pathological studies are currently underway. In particular, experts will have to find out whether the dead were infected with the coronavirus.
Most of the vaccines are produced by the Korean pharmaceutical companies GC Pharma, SK Bioscience, Korea Vaccine and Boryung Biopharma Co Ltd, Boryung Pharm Co Ltd, and vaccines from the French company Sanofi are also used for the vaccination campaign. It is known that of the 25 dead, 10 received the drug from SK Bioscience, five from Boryung, and five more from GC Pharma.
This is the second flu vaccination incident in South Korea. The vaccine campaign was previously suspended after it was revealed that about 5 million doses of the vaccine, which should only be stored frozen, were at room temperature during transport.